{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:47:35Z","timestamp":1787168855513,"version":"build-2736575974"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T00:00:00Z","timestamp":1528416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007405","name":"The Danish Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006442","name":"Det Sundhedsvidenskabelige Fakultet, K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006442","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bispebjerg\/Frederiksberg University Hospital"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196962","type":"journal-article","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T13:25:27Z","timestamp":1528464327000},"page":"e0196962","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Effect of ACE-inhibition on coronary microvascular function and symptoms in normotensive women with microvascular angina: A randomized placebo-controlled trial"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3651-3348","authenticated-orcid":true,"given":"Marie Mide","family":"Michelsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Bay","family":"Rask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Suhrs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer Flintholm","family":"Raft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nis","family":"H\u00f8st","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,6,8]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary Microvascular Dysfunction","volume":"356","author":"PG Camici","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1067\/mhj.2001.114198","article-title":"Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study","volume":"141","author":"SE Reis","year":"2001","journal-title":"Am Heart J"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.amjcard.2008.10.033","article-title":"Additive prognostic value of coronary flow reserve in patients with chest pain syndrome and normal or near-normal coronary arteries","volume":"103","author":"R Sicari","year":"2009","journal-title":"Am J Cardiol"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003064","article-title":"Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study","volume":"5","author":"ND Mygind","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcmg.2014.12.008","article-title":"Coronary microvascular dysfunction, microvascular angina, and treatment strategies","volume":"8","author":"MA Marinescu","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pcad.2014.12.002","article-title":"Regulation of Coronary Blood Flow in Health and Ischemic Heart Disease","volume":"57","author":"DJ Duncker","year":"2015","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCRESAHA.107.148338","article-title":"Angiotensin-converting enzyme and vascular remodeling","volume":"101","author":"S Heeneman","year":"2007","journal-title":"Circ Res"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.amjhyper.2004.08.014","article-title":"Arterial compliance changes in diabetic normotensive patients after angiotensin-converting enzyme inhibition therapy","volume":"18","author":"AJ Manolis","year":"2005","journal-title":"Am J Hypertens"},{"issue":"4","key":"ref9","first-page":"S21","article-title":"Acute and long-term effects of angiotensin converting enzyme inhibition on larger arteries and cardiac hypertrophy: mechanical and structural parameters","volume":"12","author":"A Benetos","year":"1994","journal-title":"J Int Soc Hypertens"},{"issue":"9299","key":"ref10","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/S0140-6736(01)07186-0","article-title":"Blood-pressure reduction and cardiovascular risk in HOPE study","volume":"358","author":"P Sleight","year":"2001","journal-title":"Lancet (London, England)"},{"key":"ref11","article-title":"Treatment strategies in coronary microvascular dysfunction: a systematic review of interventional studies","author":"HE Suhrs","year":"2017","journal-title":"Microcirculation"},{"issue":"38","key":"ref12","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"G Montalescot","year":"2013","journal-title":"Eur Heart J"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9149(02)02664-4","article-title":"Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X","volume":"90","author":"J-W Chen","year":"2002","journal-title":"Am J Cardiol"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ahj.2011.07.011","article-title":"In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)","volume":"162","author":"DF Pauly","year":"2011","journal-title":"Am Heart J"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0735-1097(02)02033-8","article-title":"Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: a comparison of lisinopril and losartan","volume":"40","author":"OO Akinboboye","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/01.HYP.0000141273.72768.b7","article-title":"Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension","volume":"44","author":"NH Buus","year":"2004","journal-title":"Hypertens (Dallas, Tex 1979)"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"798.e9","DOI":"10.1016\/j.ahj.2005.09.014","article-title":"Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonist","volume":"151","author":"T Kawata","year":"2006","journal-title":"Am Heart J"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.CIR.96.3.864","article-title":"Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension","volume":"96","author":"O Parodi","year":"1997","journal-title":"Circulation"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF02988695","article-title":"Evaluation of coronary blood flow reserve by 13N-NH3 positron emission computed tomography (PET) with dipyridamole in the treatment of hypertension with the ACE inhibitor (Cilazapril)","volume":"14","author":"D Masuda","year":"2000","journal-title":"Ann Nucl Med"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/jhh.2013.125","article-title":"Pleiotropic effects of the acute and chronic inhibition of the renin-angiotensin system in hypertensives","volume":"28","author":"K Stamatelopoulos","year":"2014","journal-title":"J Hum Hypertens"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0002-9149(97)00750-9","article-title":"Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction","volume":"80","author":"JD Schlaifer","year":"1997","journal-title":"Am J Cardiol"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/01.HYP.36.2.220","article-title":"Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease","volume":"36","author":"B Schwartzkopff","year":"2000","journal-title":"Hypertension"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.HYP.27.5.1031","article-title":"Improvement of coronary flow reserve after long-term therapy with enalapril","volume":"27","author":"W Motz","year":"1996","journal-title":"Hypertension"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/HJH.0b013e328340a08e","article-title":"Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension","volume":"29","author":"D Neglia","year":"2011","journal-title":"J Hypertens"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/jhh.2016.13","article-title":"Positive effects of aggressive vasodilator treatment of well-treated essential hypertensive patients","volume":"30","author":"M Engholm","year":"2016","journal-title":"J Hum Hypertens"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijcard.2007.08.066","article-title":"Effect of angiotensin-converting enzyme inhibitor on serum asymmetric dimethylarginine and coronary circulation in patients with type 2 diabetes mellitus","volume":"132","author":"T Kawata","year":"2009","journal-title":"Int J Cardiol"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/1056-8727(94)90003-5","article-title":"ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects","volume":"8","author":"GL Bakris","year":"1994","journal-title":"J Diabetes Complications"},{"issue":"6656","key":"ref28","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/bmj.297.6656.1092","article-title":"Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria","volume":"297","author":"M Marre","year":"1988","journal-title":"BMJ"},{"issue":"6698","key":"ref29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bmj.299.6698.533","article-title":"Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy","volume":"299","author":"HH Parving","year":"1989","journal-title":"BMJ"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/clpt.1992.20","article-title":"Dose responses and pharmacokinetics for the angiotensin converting enzyme inhibitor quinapril","volume":"51","author":"HL Elliott","year":"1992","journal-title":"Clin Pharmacol Ther"},{"issue":"12 Pt 1","key":"ref31","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00004","article-title":"Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial","volume":"128","author":"M Ravid","year":"1998","journal-title":"Ann Intern Med"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1755-3768.2009.01847.x","article-title":"Lack of effect of short-term treatment with amlodipine and lisinopril on retinal autoregulation in normotensive patients with type 1 diabetes and mild diabetic retinopathy","volume":"89","author":"J Mehlsen","year":"2011","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/qjmed\/94.2.89","article-title":"Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus","volume":"94","author":"J Kvetny","year":"2001","journal-title":"QJM Mon J Assoc Physicians"},{"issue":"3","key":"ref34","first-page":"559","article-title":"Effect of angiotensin converting enzyme inhibitor on glomerular hyperfiltration in patients with type 1 diabetes","volume":"32","author":"SAJ Naqvi","year":"2016","journal-title":"Pakistan J Med Sci"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/S1734-1140(12)70944-1","article-title":"Different effects of perindopril and enalapril on monocyte cytokine release in coronary artery disease patients with normal blood pressure","volume":"64","author":"R Krysiak","year":"2012","journal-title":"Pharmacol reports PR"},{"issue":"6794","key":"ref36","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.303.6794.81","article-title":"Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria","volume":"303","author":"ER Mathiesen","year":"1991","journal-title":"BMJ"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2337\/diacare.17.5.420","article-title":"Effects of long-term enalapril treatment on persistent micro-albuminuria in well-controlled hypertensive and normotensive NIDDM patients","volume":"17","author":"T Sano","year":"1994","journal-title":"Diabetes Care"},{"key":"ref38","first-page":"S161","article-title":"Long-term effect of ACE inhibition on development of nephropathy in diabetes mellitus type II","volume":"45","author":"M Ravid","year":"1994","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ahj.2014.01.003","article-title":"Improving diagnosis and treatment of women with angina pectoris and microvascular disease: the iPOWER study design and rationale","volume":"167","author":"E Prescott","year":"2014","journal-title":"Am Heart J"},{"issue":"7","key":"ref40","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.echo.2016.02.011","article-title":"Coronary Flow Velocity Reserve Assessed by Transthoracic Doppler: The iPOWER Study: Factors Influencing Feasibility and Quality","volume":"29","author":"MM Michelsen","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jch.12237","article-title":"Clinical Practice Guidelines for the Management of Hypertension in the Community: A Statement by the American Society of Hypertension and the International Society of Hypertension","volume":"16","author":"MA Weber","year":"2014","journal-title":"J Clin Hypertens"},{"issue":"16","key":"ref42","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA Guideline for the Management of Heart Failure","volume":"62","author":"CW Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"S Yusuf","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease","volume":"25","author":"JA Spertus","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjci\/jeu184","article-title":"Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging","volume":"16","author":"J-U Voigt","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.euje.2005.12.014","article-title":"Recommendations for chamber quantification","volume":"7","author":"RM Lang","year":"2006","journal-title":"Eur J Echocardiogr J Work Gr Echocardiogr Eur Soc Cardiol"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ejechocard\/jep007","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"10","author":"SF Nagueh","year":"2009","journal-title":"Eur J Echocardiogr J Work Gr Echocardiogr Eur Soc Cardiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijcard.2016.11.004","article-title":"Transthoracic Doppler echocardiography compared with positron emission tomography for assessment of coronary microvascular dysfunction: The iPOWER study","volume":"228","author":"MM Michelsen","year":"2017","journal-title":"Int J Cardiol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12933-015-0206-3","article-title":"Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes\u2014a randomized, single-blinded, cross-over pilot study","volume":"14","author":"R Faber","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"ref50","article-title":"Applied Longitudinal Analysis","author":"Garrett M. Fitzmaurice"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1161\/01.CIR.0000100722.34034.E4","article-title":"Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X: role of superoxide dismutase activity","volume":"109","author":"C Pizzi","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","article-title":"A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension","volume":"115","author":"AU Klingbeil","year":"2003","journal-title":"Am J Med"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/j.ajkd.2005.11.024","article-title":"Effect of Ramipril on Left Ventricular Mass in Normotensive Hemodialysis Patients","volume":"47","author":"W-C Yu","year":"2006","journal-title":"Am J Kidney Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T11:33:35Z","timestamp":1540294415000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196962"}},"subtitle":[],"editor":[{"given":"Yoshihiro","family":"Fukumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,8]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196962","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,8]]}}}